• 

  SURVEY: U.S. Alzheimer’s Diagnoses Top 7 Million for the First Time
• 

  Straight-forward Explainer: What’s Going on With NIH Cuts to Alzheimer’s Research?
• 

  FDA Bans Red 3 Dye—An Inflammation Researcher Explains Its Toxic Effects on the Brain and Beyond
• 

  ‘Unsettling:’ Federal DEI Ban a ‘Step Backward’ for Alzheimer’s Trials
• 

  ‘Mission Critical’: Why the FDA Approved an Alzheimer’s Drug Update During Comms Freeze
• 

  NIH Activities Grind to Halt Under Trump Comms Freeze
• 

  U.S. Senate Passes Act Tripling Funding to State and Local Dementia Programs
• 

  Biden Signs 2 New Laws to Protect and Expand ‘National Alzheimer’s Project’
• 

  STUDY: Climate Change Is Linked to Worsening Brain Diseases
• 

  Op-Ed: What Are Media Outlets Really Doing When They Ask About Joe Biden and Dementia?
• 

  Wegovy and Ozempic Cost So Much, U.S. Lawmakers Are Intervening
• 

  Cleaner Air Could Spare 188,000 Americans From Dementia Each Year
• 

  Alzheimer’s Rates Are Highest In These Counties—But No Leqembi Access
• 

  Dr. Indira Turney: How Racial Biases Hurt Public Health
• 

  Are Doctors Missing Millions of Cases of Mild Cognitive Impairment?

Previous123Next